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Objectives: The purposes of this study are to determine whether there is a correlation
between the Mann Assessment of Swallowing Ability (MASA) and modified MASA
(mMASA) according to various cognitive status and to investigate whether the cognitive
status of patients with brain damage affects the prediction of aspiration using the MASA.
Methods: We retrospectively assessed 146 dysphagic patients with brain lesion due to
various causes. Dysphagia was assessed using the MASA and mMASA. According to
the videofluoroscopic swallowing study results, patients were divided into two groups:
aspirators and non-aspirators. Patients were classified into four groups according to
cognitive function according to the Korean version of Mini-mental State Examination
scores: normal (>24), mild (21–24), moderate (10–20), and severe (<10) cognitive
impairment. The correlation between the MASA and mMASA scores according to
cognitive function were analyzed. The sensitivity, specificity, and positive and negative
predictive values of the MASA scores for predicting aspiration were assessed.
Results: The MASA and mMASA scores showed a significant positive correlation in all
cognition groups. In patients with more severe cognitive impairment MASA scores had
high sensitivity and low specificity for prediction of aspiration. On the other hand, the
MASA scores had low sensitivity and high specificity for prediction of aspiration in the
normal and mild cognitive impairment groups.
Conclusions: The MASA and mMASA scores correlated with each other in patients
with various levels of cognitive function. Interestingly, this study results demonstrated that
patients with good cognitive function may have false negative results of MASA screening
due to low sensitivity. Thus, when interpreting the MASA results, the impact of cognitive
status should be taken into consideration.
Keywords: dysphagia, brain injury, cognitive impairment, dysphagia screening, videofluoroscopic swallowing
study, Mann Assessment of Swallowing Ability
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INTRODUCTION
Dysphagia is a disorder of the swallowing pathway resulting
in impairment of the safety, efficiency, or quality of eating
and drinking (1). It is one of the common and important
complications of brain-injured patients, and its prevalence ranges
from 30 to 67% in patients with stroke, traumatic brain injury
(TBI), and brain tumors (2–5). Previous studies have shown that
patients with dysphagia account for up to 50% of patients with
acute stroke (6). In a clinical swallow assessment at 6 months
post-stroke, 11% of patients had dysphagia, whereas in the
videofluoroscopic swallowing study (VFSS), 50% of the patients
had dysphagia (7, 8). Dysphagia causes complications, such as
dehydration, malnutrition, asphyxia, and aspiration pneumonia,
which may delay medical recovery and extend hospital stay (9).
Aspiration pneumonia, which occurs in about 50% of cases of
post-stroke dysphagia, even increases the mortality rate up to
45% (10). Additionally, patients with TBI are 79 timesmore likely
to die of aspiration pneumonia than the general population (11).
As early screening of dysphagia and proper dietary control are
emphasized for improving the rehabilitation outcome in brain-
injured patients (11–13), screening tools are routinely used to
assess the risk of dysphagia and aspiration.
The Mann Assessment of Swallowing Ability (MASA) was
developed by Mann et al. in 2002 as a screening tool for
identifying eating and swallowing disorders in patients with
stroke. The MASA can be used to quantify the aspiration
risk via a bedside test. When predicting dysphagia in patients
with stroke, the sensitivity and specificity of the MASA are
reported as 71 and 72%, respectively. Additionally, for prediction
of aspiration, the sensitivity and specificity of the MASA are
estimated as 93 and 55%, respectively (14). The MASA is now
used for various diseases (14–16) and effective for predicting the
incidence of aspiration in a mixed-disease population (17). In
2010, Antonios et al. statistically reviewed the original data of
the MASA to identify critical items for developing a screening
tool that is quicker and more accurate to use. As a result, a more
simplified version of the MASA, the modified MASA (mMASA),
was designed to utilize highly discriminant items. The mMASA
showed a high sensitivity (92.0%) and specificity (86.3%) for a
prediction of dysphagia (15).
Both the MASA and mMASA are sensitive and specific
screening tools for dysphagia (18). However, it is unknown
whether these tests are reliable regardless of patient’s cognitive
function. Patients with impaired cognitive function may not
follow instructions and result in deviation of test results different
from the actual condition. Because MASA and mMASA contain
several items reflecting cognitive status, such as alertness,
cooperation, and auditory comprehension (19), the achieved
scores can be lower in patients with poor cognitive function.
Cognitive dysfunction is frequent in 11.6–56.3% of brain-
injured patients (20). Those with lower cognitive function are
more likely to have severe dysphagia (21). As the need for
dysphagia with aspiration screening is high in patients with
impaired cognitive function, it is necessary to investigate the
effect of cognitive function on dysphagia screening test results.
To our knowledge, no study has evaluated the impact of cognitive
impairment on the MASA and mMASA scores. Therefore, the
purposes of this study are to explore whether there is a correlation
between the MASA and mMASA according to various levels
of cognitive function and to investigate whether the cognitive
function of patients with brain damage affects the prediction of
aspiration using the MASA.
MATERIALS AND METHODS
This was a retrospective study of 146 patients who were
referred to a university hospital for consecutive VFSSs between
December 2015 and November 2017. Inclusion criteria were
as follows: (1) a brain injury (stroke, traumatic brain injury,
and brain tumor) confirmed by a neurologist using computed
tomography or magnetic resonance imaging, (2) aged ≥18
years, (3) available dysphagia evaluation results from the VFSS,
MASA, and mMASA those had been conducted within a week,
and (4) available cognitive assessment results from the Korean
version of the Mini-mental State Examination (K-MMSE), of
which evaluation date did not differ with swallowing evaluations
by more than a week. Exclusion criteria were as follows: (1)
underlying neurological conditions other than brain lesions,
such as spinal cord injury and degenerative diseases, (2) a
history of diseases that can affect swallowing function, such
as oropharyngeal disease and prior surgery of the neck or
cervical area.
Through medical chart review, patients’ sex, age, onset of
brain damage, cause and area of brain lesions, and dietary status
were collected. In addition, results of cognitive and swallowing
function assessed by the K-MMSE, VFSS, MASA, and mMASA
were collected.
This study was conducted in accordance with the
recommendations of the institutional review board (IRB)
of the CHA University hospital, and the protocol was approved
by the IRB of the CHA University hospital. The informed
consent was waived because of the retrospective study design
(ethical approval number: 2017-04-056).
Dysphagia Assessment
Mann Assessment of Swallowing Ability and Modified
Mann Assessment of Swallowing Ability
The MASA consists of 24 clinical items comprising four
main components: general patient examination (alertness,
cooperation, auditory comprehension, aphasia, apraxia,
and dysarthria); oral preparation phase (saliva, lip seal,
tongue movement, tongue strength, tongue coordination, oral
preparation, respiration, and respiratory rate for swallowing);
oral phase (gag reflex, palatal movement, bolus clearance, and
oral transit time); and pharyngeal phase (cough reflex, voluntary
cough, voice, tracheostomy, pharyngeal phase, and pharyngeal
response). The MASA score is measured using a 5-point to
10-point rating scale. The total score of the MASA is 200 points,
and the cutoff value is 177 points. The results of the MASA
are interpreted as no abnormality (≥178), mild dysphagia
(168–177), moderate dysphagia (139–167), and severe dysphagia
(≤138). The risk of aspiration are defined based on the total
scores into four categories as follows: no abnormality (≥170),
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mild (149–169), moderate (141–148), and severe (≤140) (14). In
this study, we identified the risk of aspiration based on only a
MASA score of 170.
The mMASA consists of 12 items, and the total score is
100 points with a cutoff value of dysphagia as 94. It evaluates
alertness, cooperation, respiration, expressive dysphasia,
auditory comprehension, dysarthria, saliva, tongue movement,
tongue strength, gag reflex, voluntary cough, and palatal
movements. In addition, “no response” was added as a possible
response in auditory comprehension (15). The MASA and
mMASA are performed by a skillful occupational therapist with
more than 15 years of experience in the evaluation of dysphagia.
All of MASA, mMASA, and VFSS were conducted within a week.
Videofluoroscopic Swallowing Study
The VFSS protocol from Logemann’s study (22) was performed
by a physiatrist in the fluoroscopic radiography room. In a sitting
position, the lateral views of the oropharynx and larynx were
obtained while the patient was given consecutive boluses of
semisolid, solid, thick liquid, and thin liquid barium preparations
orally. Finally, the patient was asked to drink 30ml of thin
liquid. The test was stopped when aspiration was detected on
the fluoroscopic image. The diagnostic criteria for aspiration are
as follows (8): normal, no entry of contrast material through
the true vocal cords; mild, a trace of contrast materials through
the true vocal cords; moderate, entry of <10% of the bolus
through the true vocal cords; severe, entry of >10% of the bolus
through the true vocal cords; and complete, frank aspiration of
materials through the vocal cords without an observable reaction
by the patient. Fluoroscopic images were stored on the server
system, and the physiatrist reevaluated the results based on the
recorded images. According to the VFSS results, patients were
divided into two groups: patients with aspiration (aspirators)
and those without aspiration (non-aspirators). Patients with only
mild penetration were classified as the non-aspiration group, and
the severity of aspiration in aspirators was not determined.
Assessment of Cognitive Function
Cognitive function was assessed by referring to the K-MMSE
result noted in the patients’ medical charts. TheMMSE is a widely
used evaluation tool, and it was initially designed for screening
for dementia (23). In most studies, the criterion for the presence
of cognitive impairment was indicated at 23–25 points, but the
classification of severity varied (24–27). Thus, we classified the K-
MMSE scores as follows: scores ≤24 were considered abnormal,
21–24 as mild, 10–20 as moderate, and <10 as severe cognitive
impairment (25). Cognitive function evaluation and swallowing
assessment were performed during a proximate period within
1 week.
Statistical Analysis
All variables, except for age and K-MMSE, were found to be
not normally distributed (Kolmogorov-Smirnov test) and did
not meet parametric assumptions. Differences in the distribution
FIGURE 1 | Flowchart of the study and analysis.
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TABLE 1 | Demographics and clinical characteristics of patients (n = 146).
Variable Total (n = 146) Aspirator (n = 63) Non-aspirator (n = 83) P
Age (years) 63.2 ± 15.9 61.5 ± 17.1 61.5 ± 17.1 0.216
Sex (n, M/F) 146, 90/56 63, 35/28 83, 55/28 0.187
Etiology (n, M/F) 0.632
Cerebral infarction 51, 24/27 19, 8/11 32, 16/16
Cerebral hemorrhage 58, 41/17 28, 17/11 30, 24/6
Traumatic brain injury 21, 17/4 10, 7/3 11, 10/1
Brain tumor 16, 8/8 6, 3/3 10, 5/5
Brain lesion side: Rt/Lt/bilateral 34/47/65 9/19/35 25/28/30 0.030*
Onset to evaluation: MASA (day) 67.0 ± 89.4 67.6 ± 61.6 66.5 ± 106.0 0.942
Onset to evaluation: VFSS (day) 66.8 ± 89.8 67.5 ± 61.9 66.3 ± 106.7 0.936
Interval between MASA and VFSS (day) 2.3 ± 2.0 2.2 ± 2.1 2.3 ± 2.0 0.660
K-MMSE (n, scores) 146, 13.5 ± 9.5 63, 9.6 ± 8.5 83, 16.5 ± 9.3 0.000**
Normal 22, 27.5 ± 1.3 4, 27.3 ± 0.5 18, 27.6 ± 1.5 0.690
Abnormal 124, 11.0 ± 8.1 59, 8.4 ± 7.3 65, 13.4 ± 8.1 0.000**
Values are presented as mean ± standard deviation (SD).
*p < 0.05, **p < 0.01.
TABLE 2 | Correlation between MASA and mMASA according to cognitive status.
Cognitive status (n) MASA mMASA r
Total (146) 156.2 ± 43.1 80.3 ± 20.1 0.961**
Normal (22) 182.7 ± 22.4 93.7 ± 8.8 0.896**
Abnormal (124) 151.4 ± 48.3 78.0 ± 22.4 0.974**
Mild impairment (17) 184.2 ± 14.7 93.6 ± 7.3 0.845**
Moderate impairment (53) 169.0 ± 27.9 87.0 ± 11.1 0.926**
Severe impairment (54) 124.0 ± 47.9 64.2 ± 22.2 0.973**
Values are presented as mean ± standard deviation (SD).
**p < 0.01.
of selected characteristics between the patient groups were
examined using the chi-square test for categorical variables.
Differences in continuous variables between the study groups
were analyzed using either the MannWhitney U test or t-test.
The correlation between the MASA and mMASA according
to cognitive status was analyzed using the Spearman correlation
coefficient. The data were analyzed using 2 × 2 tables to
determine the sensitivity, specificity, positive predictive value,
and negative predictive value of the MASA for predicting
aspiration according to cognitive status. Sensitivity was
calculated as the proportion of true positive aspiration detected
during the VFSS. Specificity was calculated as the proportion of
true negative tests in patients without aspiration. The predictive
value indicated the probability of aspiration based on the
test results.
The statistical analysis was performed using standard
statistical software (SPSS version 21.1 for Windows, SPSS, Inc.,
Chicago, IL, USA). The significance level was set at 0.05.
RESULTS
Among 686 patients, 510 patients were excluded because they had
no records of the K-MMSE. Three patients did not meet the age
criteria, and 27 patients were not brain-injured patients. Finally,
146 patients (90 men and 56 women; mean age 63.2± 15.9 years)
with brain injury were included (51 with ischemic stroke, 58
with hemorrhagic stroke, 21 with TBI, and 16 with brain tumor)
(Figure 1). According to the K-MMSE score, patients were
divided into two cognitive function groups: normal (n = 22),
abnormal (n= 124). The abnormal group was divided into three
subgroups: mild impairment (n = 17), moderate impairment (n
= 53), and severe impairment (n = 54). Table 1 summarizes the
demographics and clinical characteristics of patients.
The MASA and mMASA scores showed a significant positive
correlation (r = 0.961, P < 0.01) (Table 2). In subgroup analysis
of cognitive function, theMASA andmMASA scores also showed
a significant correlation within all groups.
The sensitivity and specificity of the MASA for predicting
aspiration were 71.4 and 69.9%, respectively. In the subgroup
analysis according to cognitive function, the subgroup with
severe impairment revealed the highest sensitivity of 90.9 and
the lowest specificity of 38.1. Normal cognition group had the
lowest sensitivity of 25.0 and the highest specificity of 88.9. The
patient group with more severe cognitive impairment tended
to have higher sensitivity and positive predictive values, and
lower specificity and negative predictive values of the MASA for
prediction of aspiration. On the other hand, lower sensitivity
and positive predictive values, and higher specificity and negative
predictive values of the MASA for prediction of aspiration was
observed in the normal and mild cognitive impairment groups
(Table 3).
DISCUSSION
The results of this study shows the MASA and mMASA
scores are significantly correlated regardless of patients’ cognitive
function. This finding suggests that the mMASA, which has
a similar tendency with the MASA, might be used instead of
the MASA for brain-injured patients with various degrees of
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TABLE 3 | Accuracy of MASA for prediction of aspiration according to cognitive status.
MASA Cognitive status (K-MMSE)
Total Normal Abnormal Mild impairment Moderate impairment Severe impairment
Sensitivity 71.4 25.0 74.6 50.0 50.0 90.9
Specificity 69.9 88.9 64.6 86.7 72.4 38.1
Positive predictive value 64.3 33.3 65.7 33.3 60.0 69.8
Negative predictive value 76.3 84.2 73.7 92.9 63.6 72.7
cognitive impairment. Using the mMASA, dysphagia maybe
readily and quickly screened in brain-injured patients. However,
there is still a lack of research on the mMASA for a clinical
application. Currently, the cutoff value of mMASA for dysphagia
screening has been evaluated (15), without regards to the risk of
aspiration. Therefore, the significance of mMASA in identifying
aspiration risk needs to be studied further. As this study revealed,
the sensitivity and specificity of the MASA for prediction of
aspiration change according to patient’s cognitive function.
Accordingly, further study is needed to confirm the influence of
cognitive function on the sensitivity and specificity of mMASA.
This study revealed the sensitivity and specificity of the
MASA scores for predicting aspiration based on VFSS results.
Previously, the sensitivity and specificity of the aspiration
risk have been reported as 93 and 55%, respectively (14);
however, the influence of cognitive function was not taken into
consideration. In our study, the sensitivity and specificity were
71.4 and 69.9%, respectively. In the subgroup analysis, patient
group with severe cognitive impairment revealed the highest
sensitivity of 90.9 and normal cognition group showed the lowest
sensitivity of 25.0. A high sensitivity is a prerequisite for a good
screening test. In other words, the MASA is likely to be less
considerable as a screening tool for brain-injured patients with
good cognitive function.
The MASA includes the items of alertness, cooperation, and
auditory comprehension related to patient’s cognitive function
as well as swallowing assessment items. As mentioned above,
the MASA includes evaluation items for cognitive function (total
scores of 30), and patients with cognitive impairment are more
likely to have a low score and are classified as having dysphagia or
a higher risk of aspiration. Therefore, in this study, the patients
with low cognitive function were considered to have a high
sensitivity and low specificity.
If a patient with good cognitive function has a good oral
function and only a pharyngeal phase dysfunction, his MASA
and mMASA scores can be high even the patient has aspiration.
For this reason, the normal cognition group may not show
significant difference in the MASA and mMASA scores between
aspirators and non-aspirators. From this result, we draw a careful
conclusion that theMASAmay be of less value as a screening tool
in patients with good cognitive function.
Cognitive impairment is a major and common problem in the
patients with brain lesion. In a previous study, the relationship
between dysphagia and cognitive impairment in brain-injured
patients was introduced (19). Patients with attention, cognitive-
perceptual, and behavioral disorders experience swallowing
disorders (19, 28–30). Dysphagia is more clinically relevant
in patients with non-amnestic mild cognitive impairment,
as it may interfere with motor activities (31). Dysphagia
after stroke is not only limited to brainstem involvement,
and silent aspiration is more likely to occur (32). Patients
with significant sensory deficits also have increased risk of
aspiration (33). Brain-injured patients with severe cognitive
impairment would have more severe swallowing problems
and higher aspiration risk. However, prior studies have
analyzed only the relationship between the MASA, mMASA
and VFSS without consideration of cognitive function. To
the best of our knowledge, this is the first study to assess
the effect of cognitive function on the results of dysphagia
screening tools.
This study defined the cognitive function level of the patients
based on the MMSE. As this study utilized the retrospective data
collection, the analysis of cognitive function had limited data set.
The MMSE is a tool that was initially developed for diagnosing
dementia (34), however, it is also widely used for evaluating
cognitive impairment (25, 27). TheMMSE has a weakness lacking
assessment of frontal lobe function and focusing primarily on
left hemispheric cognitive function (language, verbal memory,
calculation, etc.) (27, 35). Nevertheless, the validity of the MMSE
is still acceptable, and it has advantages of being easy to use and
has a low inter-rater variability (27, 36–39).
The present study has other limitations. There is a
lack of homogeneity in the subject population, including
various etiology of brain damage. In addition, the number
of subjects with good cognitive function was much smaller
than those with severe cognitive impairment. Future studies
should be conducted on more homogenous samples with
various cognitive function to identify the cognitive effects on
the results of dysphagia screening. Through the prospective
studies, we should consider using cognitive assessment tools
which represent the minor deficit and overall function of the
brain (40, 41).
CONCLUSIONS
The MASA and mMASA scores correlated with each other in
patients with various cognitive function. However, the sensitivity
and specificity of theMASAmay vary depending on the cognitive
level of brain-injured patients. Thus, the test results should
be interpreted carefully considering the impact of cognitive
function on the MASA scores. Especially for the patients with
relatively good cognitive function, it is helpful to recognize
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the possibility of false negative result of MASA study for the
prediction of aspiration.
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